index,Regulator Name,Regulator Type,Regulator Subtype,Regulator HGNC Symbol,Regulator Database,Regulator ID,Regulator Compartment,Regulator Compartment ID,Regulated Name,Regulated Type,Regulated Subtype,Regulated HGNC Symbol,Regulated Database,Regulated ID,Regulated Compartment,Regulated Compartment ID,Sign,Connection Type,Mechanism,Site,Cell Line,Cell Type,Tissue Type,Organism,Score,Source,Statements,Paper IDs,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
50,braf,protein,,braf,hgnc,1097,,,tert,protein,,tert,hgnc,11730,,,positive,i,increaseamount,,,,,,0.65,nan,"the acquisition of tert promoter mutation in braf or nras mutated melanoma probably allows the re-expression of tert leading to the immortalization process on path to melanoma development, together with other alterations such as inactivation of cyclin dependent kinase inhibitor 2a (cdkn2a).",pmc5288173,1,10,5,1,15
324,mtor,protein,,mtor,hgnc,3942,,,autophagy,biologicalprocess,,,go,go:0006914,,,positive,i,activation,,,,,,0.65,nan,it is well known that autophagy can be activated either by mtor down regulation or ampk activation [xref_bibr - xref_bibr].,pmc5723691,1,10,5,1,15
325,mtor,protein,,mtor,hgnc,3942,,,braf,protein,,braf,hgnc,1097,,,negative,i,inhibition,,,,,,0.65,nan,"xref_bibr, xref_bibr another preclinical study demonstrated that the combination of selumetinib and a mammalian target of rapamycin (mtor) inhibitor (azd8055) which is downstream of pi3k and akt pathway, induces tumor regression in braf mutant uveal melanoma cell lines but not gnaq mutant cell lines.",pmc4179759,1,10,5,1,15
113,egfr,protein,,egfr,hgnc,3236,,,kras,protein,,kras,hgnc,6407,,,positive,i,activation,,,,,,0.65,nan,"as such, there has been no clear relationship between kras mutation status and clinical outcomes in patients treated with the egfr tyrosine kinase inhibitors gefitinib or erlotinib [xref_bibr].",pmc2911390,1,10,1,1,11
286,mdm2,protein,,mdm2,hgnc,6973,,,tp53,protein,,tp53,hgnc,11998,,,negative,i,inhibition,,,,,,0.65,nan,"interestingly, hdac inhibitors have been previously implicated in the depletion of mutant p53 through the transcriptional induction of mdm2, an e3 ubiquitin ligase that negatively regulates p53, instead of directly affecting tp53 transcription (blagosklonny etal., 2005).",pmc5537703,1,10,1,1,11
